Status:

COMPLETED

Acute Effects of an Herbal Tea on Immune Surveillance and Activation.

Lead Sponsor:

Natural Immune Systems Inc

Conditions:

Active Immune Response

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

A small cross-over trial on 24 people involving an herbal tea blend to test whether consuming 1 cup of tea triggers changes in the numbers of natural killer cells in the blood circulation as evidence ...

Detailed Description

A randomized, cross-over, controlled study design will be used to evaluate the effects of consumption of 1 cup of an herbal tea blend to consumption of the same volume of warm water. The study is of 3...

Eligibility Criteria

Inclusion

  • Healthy adults;
  • Age 18-75 years (inclusive);
  • Veins easy to see in both arms (to allow for the multiple blood draws);
  • Willing to comply with a 24-hour wash-out period for vitamins and nutritional supplements;

Exclusion

  • Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery not a problem, including previous removal of appendix and gall bladder);
  • Taking anti-inflammatory medications on a daily basis;
  • Currently experiencing intense stressful events/ life changes;
  • Currently in intensive athletic training (such as marathon runners);
  • Currently taking antipsychotic medications such as clozapine, Risperdal, Abilify, Zyprexa or Seroquel;
  • Actively depressed;
  • An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying);
  • Unwilling to maintain a constant intake of supplements over the duration of the study;
  • Anxiety about having blood drawn;
  • Women of childbearing potential: Pregnant, nursing, or trying to become pregnant;
  • Known food allergies related to ingredients in active test product.

Key Trial Info

Start Date :

July 27 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 19 2021

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT04491461

Start Date

July 27 2020

End Date

December 19 2021

Last Update

September 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gitte Jensen

Klamath Falls, Oregon, United States, 97601-5904